Can waiting before surgery save fertility? new study investigates

NCT ID NCT07421895

First seen Feb 22, 2026 · Last updated Jun 19, 2026 · Updated 14 times

Summary

This study follows 600 women with retained products of conception (RPOC) to compare drug-assisted expectant management versus immediate surgery. The goal is to see which approach reduces uterine scarring and preserves the ability to get pregnant in the future. Researchers will track complications, need for repeat procedures, and pregnancy rates within one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETAINED PRODUCTS OF CONCEPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Third Xiangya Hospital of Central South University

    RECRUITING

    Changsha, Hunan, 410013, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify the best approach to treat retained pregnancy tissue while preserving fertility and reducing the need for repeat surgery.

What could go wrong

This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.